TUPDD0101:W ILL A MULTIPLEX ASSAY DETECT NEW INFECTIONS OF HIV, S YP, H EP C AND B IN U RBAN I NDIA ? 1.Detect New infections of HIV, Hepatitis C, syphilis.

Slides:



Advertisements
Similar presentations
Management of ART in Albania : From the European Guidelines to the real practice. Arjan Harxhi MD, MSc, PhD University Hospital Center of Tirana Mother.
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
HIV Counselling and Testing
Increasing the predictive value of clinic- based rapid HIV antibody screening using oral fluid and whole blood testing in 10 NYC STD clinics, New York.
Saotharlann Náisiúnta Tagartha Viris UCD UCD National Virus Reference Laboratory Dr. Jeff Connell Assistant Director National Virus Reference Laboratory.
Dr. Kate Templeton SPAIIN –Stirling Overview HIV Infection Tests used in diagnostic labs How to access them Challenges HIV prevention Non –conformity.
CHER Trial: Early Antiretroviral Therapy and Mortality Among HIV- Infected Infants New England J Med 2008;359 (21):
1 Chronic HBV: Current Management Natalie Bzowej, MD, PhD, FRCPC Director Transplant Research Ochsner Medical Center New Orleans, LA.
Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD.
Integrating Rapid HIV Testing in Emergency Care Improves HIV Detection Evan M. Cadoff, MD Robert Wood Johnson Medical School New Brunswick, NJ
Implementing screening for acute HIV infection in STD clinics already using rapid HIV antibody testing, New York City, 2007 Kathleen D. Gallagher, MPH.
Wyoming Department of Health-Communicable Diseases
12/6/07 v.3CDC 2007 HIV Diagnostic Conference1 Diagnosis of HIV-1 Infection in Phase I & II HIV Vaccine Trials RW Coombs 1, J Dragavon 1, B Metch 2, CJ.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Counseling Message: Both rapid tests we ran today were preliminary positive. It is likely that you have HIV. We always want to make absolutely sure, though,
Evaluation of Rapid Screening Methods for Emergency Blood Collections CPT Robert.
F. Kourgia, M. Vini, E. Zervou
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Management of Risk and Blood Availability in Donor Populations with High Prevalence of Blood Borne Pathogens Ravi Reddy IBSF Meeting 20 March 2015.
Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for.
Prevalence of Thalassemia Major and Hepatitis C March 2013 In collaboration with Children’s Liver Foundation (Sukhbir Kaur) THINK Foundation (Vinay Shetty)
HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
VETERANS HEALTH ADMINISTRATION Clinical Case Registries (CCR): Local and National Registries to Improve HIV Care Lisa I. Backus MD PhD Population Health/Office.
And the order changeth …. Evolving protocols for TTI testing
Reentry for Donors Deferred Based on Anti-HBc Test Results November 3, 2005 BPAC Meeting FDA/CBER/OBRR/DETTD.
Figure 1 A Case Series of Discordant Laboratory Results with Statewide Rapid HIV Testing in New Jersey Eugene G Martin, PhD 1, Gratian Salaru, MD 1, Sindy.
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
1 Predictors of Retention in Care Among HIV+ and At-Risk Youth Sion Kim Harris, PhD Cathryn L. Samples, MD, MPH Peter Keenan, RN, C-PNP Durrell J. Fox,
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
21th VHPB meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 RESIDUAL RISK OF TRANSFUSION-
RESULTS Rapid testing started at one publicly funded counseling and testing site in New Jersey on November 1, Through December 31, 2004, 48 sites.
Reducing the Delay: Can a Rapid HIV Test Discriminate False Positives as Effectively as a Western Blot – the NJ Experience Eugene G. Martin, Ph.D. *, Gratian.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Establishment of the 1st WHO International Standard for Detection of Antibodies to Hepatitis B Virus Core Antigen (anti-HBc) SoGAT XXI 29 May 2009 Dr.
Survey of hepatites VirusRelationshipTransmission HAVPicornavirusfaecal-oral HBVSpecial group of DNA viruses sexual, blood HCV (+ HGV)Flavivirusblood HDVDelta.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:
TUPDD0104: Will an innovative, unsupervised HIV self-testing strategy work in health care professionals? A feasibility study from South Africa Primary.
In the Footsteps of the WHO – Rapid HIV Testing in America Eugene Martin, Ph.D. *, Gratian Salaru, M.D. *, Sindy M. Paul, M.D., M.P.H.**, Evan Cadoff,
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
HBV screening Further improvement of blood safety based on the knowledge deduced from the results on analysis of the donor’s sera positive for HBV DNA.
ADAP and Hepatitis B Coverage  In June 2012, 29 ADAPs covered at least one of the medications for HBV on their formularies.  ADAPs filled 325 hepatitis.
GI BLOCK; This practical class is designed and Prepared by: Prof. Samy A. Azer (Medical Education) Dr. Ali Somily (Microbiology) Prof. Abdul Mageed.
Paul Klapper Clinical Virology Manchester Royal Infirmary hepatitis C dried blood spot testing.
Management of Donors and Units that Test HBV NAT Positive: Current Considerations July 21, 2005 BPAC Meeting Robin Biswas, M.D. FDA/CBER/OBRR/DETTD.
MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.
ProgressionOf HIV Infection Cases Diagnosed in Florida Through 2011 Florida Department of Health HIV/AIDS & Hepatitis Program Annual data as of 07/31/2012.
 YEOH HUI SHIH –INTRODUCTION TO HIV  RAJAMANI- ELISA  TIEN WEI PING – WESTERN BLOTTING  YEO HUI YUN –OVERVIEW & CONCLUSION.
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
Prevention of Viral Hepatitis B in Republic of Korea Ok Park, M.D., Ph.D., MPH Vaccine-Preventable Disease Control & National Immunization Program Korea.
RETROVIRIDAE GENUS: ONCOVIRUS: HTLV-1 and HTLV-2 SPUMAVIRUS LENTIVIRUS: HIV-1 and HIV-2.
Hepatitis Tutoring By Alaina Darby.
In The Name of God.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Outline Introductory Comments Origins of HIV
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
Knowledge of transmission Sharing of sharp objects
DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV
HIV TESTING SWBAT: Develop an understanding of testing for HIV /AIDS
Hepatitis Primary Care: Clinics in Office Practice
INTEGRATING HIV AND HCV TESTING.
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections.
NUCLEIC ACID AMPLIFICATION TESTING DETECTS HIV TRANSMISSION RISK IN SEROLOGICALLY- TESTED BLOOD DONOR UNITS. |Presented by Miss Shemau Muniru| Authors:
A CASE SERIES OF DISCORDANT LABORATORY RESULTS WITH RAPID HIV TESTING
Hepatitis Training in a STD Clinical Program
Share your thoughts on this presentation with #IAS2019
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

TUPDD0101:W ILL A MULTIPLEX ASSAY DETECT NEW INFECTIONS OF HIV, S YP, H EP C AND B IN U RBAN I NDIA ? 1.Detect New infections of HIV, Hepatitis C, syphilis and Hepatitis B 2.Feasibility of conduct 3.Diagnostic accuracy 4.Client preference P OPULATION I NTERVENTION S ETTING Hinduja National Hospital and Medical Research Center, and Sion Hospitals Mumbai, India Point of care + combined counselling+ confirmatory testing STD Clinic attendees Sion Hospital, Mumbai O BJECTIVE Mumbai Urban Poor Miriad TM test on fingerstick blood

F LOW OF PARTICIPANTS

C ATEGORY S ENSITIVITY S PECIFICITY R EFERENCE S TANDARD Index test status P RELIMINARY P OSITIVE Index test status P RELIMINARY N EGATIVE HIV 100% [95%, CI: 94.8, 100] 99.7% [95%, CI: 98.3, 99.9] ELISA (antigen+antibody) + Western Blot ELISA HBV 13.3% [95%, CI: 6.6, 23.2] 99.3% [95%, CI: 97.6, 99.9] HBsAg + Total anti HBc + HBV DNA HBsAg + anti-HBc HCV 50% [95%, CI: 1.26, 98.74] 99.7% [95%, CI: 98.5, 99.9] HCV antibody + HCV RNA Anti HCV screening test (EIA based) Syphilis 86.1% [95%, CI: 70.5, 95.3] 85.2% [95%, CI: 80.9, 88.8] TRUST + TPHATPHA R ESULTS Demographics Gender83% males Age (mean)31.2 years Sample size 375 STD Clinic attendees N ITIKA P ANT P AI, MD, MPH, PhD Assistant professor McGill University, Montreal Co-investigators: Dr Anjali Shetty Hinduja Dr Rachita Dhurat, Sion